Latest updates from Hudson River Biotechnology
Prof. Enrico Mastrobattista joins Hudson River Biotechnology’s Scientific Advisory Board and will advise on nanoparticle delivery
Professor Enrico Mastrobattista, full professor of Pharmaceutical Biotechnology & Delivery at the department of Pharmaceutical Sciences of Utrecht University, joins
Computomics and Hudson River Biotechnology Collaborate in Optimizing Plant Breeding with CRISPR
Computomics and Hudson River Biotechnology (HRB) will start offering AccelATrait™, a joint end-to-end solution using CRISPR-based gene editing for novel
Prof. Patricia Dankers joins Hudson River Biotechnology’s Scientific Advisory Board
Prof. Patricia Dankers, full professor of Biomedical Materials & Chemistry at the department of Biomedical Engineering and the Institute for
Hudson River Biotechnology raises €5m Series A funding to accelerate growth of its plant gene editing business and expand into nanoparticles for use in field applications
Ferdinand Los, CSO at Hudson River Biotechnology: “We strongly believe in our ability to keep innovating and be at the
Opinion piece in Agfunder: A sole focus on organic farming will not get us where we need to be
In an opinion piece on AgFunder, our founders Rudi Ariaans and Ferdinand Los argue that CRISPR is the best tool the EU has to achieve
Company profile of Hudson River Biotechnology in Bionieuws
Bionieuws, the Dutch magazine for biologists interviewed our CSO Ferdinand Los, and published a short company profile in their magazine. Read
Prof. John van der Oost joins Hudson River Biotechnology’s Scientific Advisory Board
Prof. John van der Oost, head of the Bacterial Genetics group in the Laboratory of Microbiology at Wageningen University, has
Hudson River Biotechnology (HRB) names Gabino Sánchez as Sales & Business Development Director.
>> download a pdf version of the press release